Compound class:
Synthetic organic
Comment: Compound 3 is the lead for a novel series of antimalarial compounds based on a benzimidazole core [1].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Guide to Malaria Pharmacology Comments |
A phenotypic high-throughput screen of the Novartis chemical library, followed by a hit to lead effort, identified compound 3 as an early lead with promising antimalarial activity [1]. SAR analysis was carried out but further optimization will be necessary to improve pharmacokinetic properties and address potential cardiotoxicity issues. Potential Target/Mechanism Of Action: As the precise mechanism of action of compound 3 is not yet known, we do not have a molecular target for this compound. |